OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RVHL59

Riverstone Holdings Ltd

Medical Equipment, Supplies & DistributionVerified

Riverstone Holdings Ltd maintains a strong liquidity position, with a current ratio of 9.23 and no long-term debt, indicating a robust balance sheet and minimal leverage. The company holds MYR 294.96 million in cash and equivalents, which is a significant portion of its total assets of MYR 1.64 billion. This liquidity provides the company with flexibility to fund operations and invest in growth opportunities without relying on external financing. In terms of profitability, the company generates a return on equity (ROE) of 14.08% and a return on assets (ROA) of 12.67%, both of which are strong indicators of efficient capital use and asset management. These returns are well above the typical thresholds for the healthcare equipment and supplies industry, suggesting that Riverstone Holdings Ltd is outperforming its peers in terms of profitability. The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the available data. This lack of diversification could pose a concentration risk if the company's primary market experiences economic or regulatory challenges. However, the absence of long-term debt and the strong liquidity position mitigate some of the associated risks. Looking ahead, the company's growth trajectory appears stable, with a revenue of MYR 995.31 million in the latest reporting period. While no specific growth projections are provided, the company's strong cash flow from operations and low debt levels suggest that it is well-positioned to sustain or even accelerate growth in the coming years. The risk assessment indicates that the company faces low liquidity and dilution risks. There are no immediate filing-based liquidity or dilution flags, and the company's capital structure is currently free of long-term debt. This suggests that the company is not under pressure to raise additional capital in the near term, reducing the likelihood of equity dilution. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's free cash flow was negative at MYR -100.95 million in the latest period, primarily due to capital expenditures of MYR -83.76 million. This suggests that the company is investing in its operations, which could support future growth.

30-day price · RVHL+0.22 (+29.3%)
Low$0.72High$0.97Close$0.97As of25 May, 00:00 UTC
Profile
CompanyRiverstone Holdings Ltd
TickerRVHL.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Riverstone Holdings Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in Malaysia and potentially other markets.

Classification. Riverstone Holdings Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Riverstone Holdings Ltd maintains a strong liquidity position, with a current ratio of 9.23 and no long-term debt, indicating a robust balance sheet and minimal leverage. The company holds MYR 294.96 million in cash and equivalents, which is a significant portion of its total assets of MYR 1.64 billion. This liquidity provides the company with flexibility to fund operations and invest in growth opportunities without relying on external financing. In terms of profitability, the company generates a return on equity (ROE) of 14.08% and a return on assets (ROA) of 12.67%, both of which are strong indicators of efficient capital use and asset management. These returns are well above the typical thresholds for the healthcare equipment and supplies industry, suggesting that Riverstone Holdings Ltd is outperforming its peers in terms of profitability. The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the available data. This lack of diversification could pose a concentration risk if the company's primary market experiences economic or regulatory challenges. However, the absence of long-term debt and the strong liquidity position mitigate some of the associated risks. Looking ahead, the company's growth trajectory appears stable, with a revenue of MYR 995.31 million in the latest reporting period. While no specific growth projections are provided, the company's strong cash flow from operations and low debt levels suggest that it is well-positioned to sustain or even accelerate growth in the coming years. The risk assessment indicates that the company faces low liquidity and dilution risks. There are no immediate filing-based liquidity or dilution flags, and the company's capital structure is currently free of long-term debt. This suggests that the company is not under pressure to raise additional capital in the near term, reducing the likelihood of equity dilution. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's free cash flow was negative at MYR -100.95 million in the latest period, primarily due to capital expenditures of MYR -83.76 million. This suggests that the company is investing in its operations, which could support future growth.
Key takeaways
  • Riverstone Holdings Ltd has a strong liquidity position with a current ratio of 9.23 and no long-term debt.
  • The company generates high returns on equity (14.08%) and assets (12.67%), indicating efficient capital use.
  • The company's revenue is concentrated in a single segment, which could pose a concentration risk.
  • The company is investing in its operations, as evidenced by capital expenditures of MYR -83.76 million.
  • The company faces low liquidity and dilution risks, with no immediate filing-based flags.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$995.3M
Gross profit$298.7M
Operating income$264.5M
Net income$207.8M
R&D
SG&A
D&A
SBC
Operating cash flow$306.3M
CapEx-$83.8M
Free cash flow-$100.9M
Total assets$1.64B
Total liabilities$163.9M
Total equity$1.48B
Cash & equivalents$295.0M
Long-term debt$0.00
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.48B
Net cash$295.0M
Current ratio9.2
Debt/Equity0.0
ROA12.7%
ROE14.1%
Cash conversion1.5%
CapEx/Revenue-8.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricRVHLActivity
Op margin26.6%3.9% medp25 -31.3% · p75 14.4%top quartile
Net margin20.9%2.4% medp25 -30.5% · p75 11.1%top quartile
Gross margin30.0%46.7% medp25 28.2% · p75 63.1%below median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-8.4%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity0.0%17.9% medp25 2.7% · p75 52.2%bottom quartile
Observations
IR observations
Mean price target0.87 MYR
Median price target0.82 MYR
High price target1.05 MYR
Low price target0.78 MYR
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count3.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.14 MYR
Last actual EPS0.14 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 04:40 UTC#4a212525
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 06:44 UTCJob: 7568a81a